FOR IMMEDIATE RELEASE
CONTACT:
John Lewis
[email protected]
202.464.2310
ACRO Webinar on Privacy and R&D
ACRO and ExL Pharma Co-sponsoring Webinar on How Privacy Provisions of Stimulus Bill will Effect Biopharma R&D
May 19, 2009– WASHINGTON, DC – The Association of Clinical Research Organizations (ACRO) is pleased to partner with ExL Pharma to produce a webinar: “From HIPAA 1 to HIPAA 2 – Implications of the New Health Information Privacy Security Requirements for Biopharma R&D.” The webinar, which is free to ACRO members, is being held June 4, 2009 from 1:00 PM to 3:00 PM, EDT.
The webinar is being led by ACRO Executive Director Doug Peddicord, PhD, with Dr. Don Detmer, President and CEO of the American Medical Informatics Association and Ellis Parry, Global Privacy Officer for AstraZeneca (invited).
Topics covered include:
- Changes to HIPAA enacted by the American Recovery and Reinvestment Act (ARRA);
- Implications of new health information privacy/security requirements for research sponsors, CROs and researchers;
- The potential operational, legal and other responses to regulations and guidances to be promulgated over the next 6-18 months;
- Concerns for pharmaceutical companies, biotechs, CROs, and research sites
Standard pricing for the event for non-ACRO members is $395. For more information, please visit www.exlpharma.com/hipaa2. ACRO members please call 703.865.4077 to receive your free registration.
About ACRO
The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 70,000 professionals worldwide. For more information, please visit www.www.acrohealth.org.